A Randomized Phase 2 Trial of Atezolizumab and Bevacizumab in Combination With SRF388 or Placebo in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma.

  • Roberts, Stuart (Primary Chief Investigator (PCI))
  • Lewis, Paula (Project Manager)
  • Matos, Marco (Chief Investigator (CI))
  • Zekry, Amany (Chief Investigator (CI))
  • Haridy, James (Chief Investigator (CI))

Project: Research

Project Details

StatusNot started


  • Hepatology
  • Hepatocellular carcinoma
  • Clinical trial